Quick Takeaways
- Jesse Goodman has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $224,833.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jesse Goodman
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Jesse Goodman is at least $224,833 dollars as of 02 Jul 2025. Jesse Goodman is the Director of Intellia Therapeutics, Inc. and owns shares of Intellia Therapeutics, Inc. (NTLA) stock worth about $224.8K.
- Signature
- /s/ James Basta, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jesse Goodman and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Intellia Therapeutics, Inc. ($224,833).
- Past-year value change for that position: -$29,068.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jesse Goodman
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | Director | $224,833 | -$29,068 | -11% | 30 Jun 2025 |
| PHGE | BiomX Inc. | Director | 14 Apr 2025 |
Insider Transactions Reported by Jesse Goodman:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.